Evidence map›Paper›PMID 41607818›Full record

ArticleWorld journal of transplantation2026

Preformed

Oumaima Guissouss, Khalid Achiaou, Joumana El Turk, Asmaa Mourachid, Abdelhadi Cheggali, Ghislaine Medkouri, Benyounes Ramdani, Mohammed Benghanem Gharbi, Majda Taoudi Benchekroun, Siham Bennani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Oumaima GuissoussFaculty of Sciences Ain Chock, Laboratory of Integrative Biology, University Hassan II, Casablanca 20100, Morocco.
Khalid AchiaouHistocompatibility Laboratory, Institute Pasteur of Morocco, Casablanca 20360, Morocco.
Joumana El TurkFaculty of Health Sciences, Health Sciences Research Laboratory, International University of Casablanca, Casablanca 50169, Morocco.
Asmaa MourachidDepartment of Nephrology, Dialysis, and Kidney Transplantation, Ibn Rochd University Hospital Center, Casablanca 20250, Morocco.
Abdelhadi CheggaliDepartment of Nephrology, Dialysis, and Kidney Transplantation, Ibn Rochd University Hospital Center, Casablanca 20250, Morocco.
Ghislaine MedkouriDepartment of Nephrology, Dialysis, and Kidney Transplantation, Ibn Rochd University Hospital Center, Casablanca 20250, Morocco.
Benyounes RamdaniDepartment of Nephrology, Dialysis, and Kidney Transplantation, Ibn Rochd University Hospital Center, Casablanca 20250, Morocco.
Mohammed Benghanem GharbiDepartment of Nephrology, Dialysis, and Kidney Transplantation, Ibn Rochd University Hospital Center, Casablanca 20250, Morocco.
Majda Taoudi BenchekrounFaculty of Sciences Ain Chock, Laboratory of Integrative Biology, University Hassan II, Casablanca 20100, Morocco.
Siham BennaniHistocompatibility Laboratory, Institute Pasteur of Morocco, Casablanca 20360, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDonor-specific antibodies (DSAs) against human leukocyte antigen (HLA)-DQ are increasingly recognized as major contributors to antibody-mediated rejection (AMR) and graft failure in kidney transplantation. However, their clinical impact remains understudied in Morocco.

aimTo evaluate the presence and implications of anti-HLA-DQ DSAs in Moroccan kidney transplant recipients.

methodsWe retrospectively analyzed the immunological profiles and clinical outcomes of kidney transplant recipients screened for anti-HLA antibodies between 2015 and 2020, who developed anti-HLA-DQ DSAs either before or after transplantation. Anti-HLA antibodies were identified using Luminex

resultsIn the pre-transplant group (

conclusionOur findings underscore the clinical significance of anti-HLA-DQ DSAs in Moroccan kidney transplant recipients. While preformed DSAs with low immunogenicity may permit successful transplantation,

Indexed as

Antibody-mediated rejectionBanff classificationDe novo donor-specific antibodieDonor-specific antibodiesHuman leukocyte antigens DQKidney transplantationMorocco

Identifiers

PMID41607818
PMCPMC12836199

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.